This Medudy course is a video tutorial for physicians on the topic of "Perioperative CTX or preoperative RCTX in esophageal cancer". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you.
For resectable, locally advanced adenocarcinomas of the oesophagus, multimodal treatment approaches have become the most important treatment method. Both preoperative radiochemoradiotherapy, known as the CROSS regimen, and perioperative chemotherapy, such as the FLOT regimen, have shown improved survival rates. However, the best multimodal approach is still unclear. Today's study was specifically designed to answer the question of whether perioperative chemotherapy is preferable to preoperative radiochemotherapy.
Note: All "speakers" appearing in the Medudy videos are AI-based avatars used to improve the didactics of the videos. The people on whom the avatars are based have explicitly consented to their use. All content is based on high-quality scientific sources and is created and reviewed by the Medudy medical team.
At the end of this course you will know
- the clinical background and relevance of the research question under investigation
- the study design and methodology of the publication to answer the research question
- the results and key takeaways of the publication
- the conclusion of the publication and possible limitations
